Exposure to sibutramine during pregnancy

Facundo Garcia-Bournissen, Alon Shrim, Gideon Koren

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations


QUESTION: One of my patients who was taking sibutramine to lose weight found out that she had unexpectedly conceived. The medication was stopped as soon as she found out, about 5 weeks into the pregnancy. Is the baby at risk? Should the pregnancy be aborted? ANSWER: No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations. Nevertheless, this medication should be avoided whenever possible during pregnancy, as there is little information on its effects.

Original languageEnglish
Pages (from-to)229-230
Number of pages2
JournalCanadian Family Physician
Issue number2
StatePublished - Feb 2007


Dive into the research topics of 'Exposure to sibutramine during pregnancy'. Together they form a unique fingerprint.

Cite this